Anti-Arrhythmia Agents

Displaying 1 - 4 of 4CSV
Reiffel, J. A., Blomström-Lundqvist, C., Boriani, G., Goette, A., Kowey, P. R., Merino, J. L., Piccini, J. P., Saksena, S., & Camm, A. J. (2023). Real-world utilization of the pill-in-the-pocket method for terminating episodes of atrial fibrillation: data from the multinational Antiarrhythmic Interventions for Managing Atrial Fibrillation (AIM-AF) survey. Europace, 25(6). https://doi.org/10.1093/europace/euad162
Publication Date
Gandhi, S. K., Reiffel, J. A., Boiron, R., & Wieloch, M. (2021). Risk of Major Bleeding in Patients With Atrial Fibrillation Taking Dronedarone in Combination With a Direct Acting Oral Anticoagulant (From a U.S. Claims Database). The American Journal of Cardiology, 159, 79–86. https://doi.org/10.1016/j.amjcard.2021.08.015
Publication Date